4//SEC Filing
CARR EDWARD 4
Accession 0001493152-21-008025
CIK 0000318306other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 6:31 PM ET
Size
7.4 KB
Accession
0001493152-21-008025
Insider Transaction Report
Form 4
CARR EDWARD
Chief Accounting Officer
Transactions
- Sale
Common stock
2021-04-01$1.85/sh−20,445$37,866→ 226,291 total - Sale
Common stock
2021-04-05$1.80/sh−35,000$62,846→ 191,291 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Edward Carr on February 23, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.7893 to $1.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.76 to $1.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
Documents
Issuer
ABEONA THERAPEUTICS INC.
CIK 0000318306
Entity typeother
Related Parties
1- filerCIK 0001273351
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 6:31 PM ET
- Size
- 7.4 KB